Authors:
RE A
VIJAYARAGHAVAN K
BASADE MM
HE SH
GULATI SC
Citation: A. Re et al., LONG-TERM CRYOPRESERVATION - SUCCESSFUL TRILINEAGE ENGRAFTMENT AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION WITH BONE-MARROW CRYOPRESERVED FOR 7 YEARS, Journal of hematotherapy, 7(2), 1998, pp. 185-188
Citation: M. Jhanwaruniyal et Sc. Gulati, P53 GENE MUTATION IN THE BONE-MARROW OF A PATIENT WITH DIFFUSE MIXED CELL-TYPE LYMPHOMA AT DIAGNOSIS PREDICTING EVENTUAL PROGRESSION TO LARGE-CELL LYMPHOMA, Leukemia & lymphoma, 29(3-4), 1998, pp. 415
Authors:
BOULAD F
KERNAN NA
LAQUAGLIA MP
HELLER G
LINDSLEY KL
ROSENFIELD NS
ABRAMSON SJ
GERALD WL
SMALL TN
GILLIO AP
GULATI SC
OREILLY RJ
GHAVIMI F
Citation: F. Boulad et al., HIGH-DOSE INDUCTION CHEMORADIOTHERAPY FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION AS CONSOLIDATION THERAPY IN RHABDOMYOSARCOMA, EXTRAOSSEOUS EWINGS-SARCOMA, AND UNDIFFERENTIATED SARCOMA, Journal of clinical oncology, 16(5), 1998, pp. 1697-1706
Authors:
GREENBERG P
ADVANI R
KEATING A
GULATI SC
NIMER S
CHAMPLIN R
KARANES C
GORIN NC
POWLES RL
SMITH A
LAMBORN K
CUFFIE C
Citation: P. Greenberg et al., GM-CSF ACCELERATES NEUTROPHIL RECOVERY AFTER AUTOLOGOUS HEMATOPOIETICSTEM-CELL TRANSPLANTATION, Bone marrow transplantation, 18(6), 1996, pp. 1057-1064
Citation: Mm. Basade et Sc. Gulati, HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW STEM-CELL RESCUE IN LUNG-CANCER, Lancet, 347(9005), 1996, pp. 847-848
Citation: Sc. Gulati et Jd. Bitran, COST-EFFECTIVENESS ANALYSIS - SLEEPING WITH AN ENEMY OR A FRIEND, Journal of clinical oncology, 13(9), 1995, pp. 2152-2154
Citation: M. Jhanwaruniyal et al., IDENTIFICATION OF PH(1)-CHROMOSOME IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA - CORRELATION BETWEEN RESULTS OF CYTOGENETIC AND FLUORESCENT IN-SITU HYBRIDIZATION ANALYSES, Blood, 86(10), 1995, pp. 3171-3171
Authors:
TAFURI A
LEMOLI RM
CHEN R
GULATI SC
CLARKSON BD
ANDREEFF M
Citation: A. Tafuri et al., COMBINATION OF HEMATOPOIETIC GROWTH-FACTORS CONTAINING IL-3 INDUCE ACUTE MYELOID-LEUKEMIA CELL SENSITIZATION TO CYCLE-SPECIFIC AND CYCLE NONSPECIFIC DRUGS, Leukemia, 8(5), 1994, pp. 749-757
Citation: Sc. Gulati, DID WE FOCUS ON THE MOST IMPORTANT ISSUES IN THE USE OF GROWTH-FACTORS AND STEM-CELL TRANSPLANTATION, Journal of clinical oncology, 12(4), 1994, pp. 650-652
Authors:
LEMOLI RM
TAZZARI PL
FORTUNA A
BOLOGNESI A
GULATI SC
STIRPE F
TURA S
Citation: Rm. Lemoli et al., POSITIVE SELECTION OF HEMATOPOIETIC CD34(-CELLS PROVIDES INDIRECT PURGING OF CD34(-) LYMPHOID-CELLS AND THE PURGING EFFICIENCY IS INCREASEDBY ANTI-CD2 AND ANTI-CD30 IMMUNOTOXINS() STEM), Bone marrow transplantation, 13(4), 1994, pp. 465-471